• Eli Lilly and Company (LLY) and Abbott Laboratories (ABT) Win Big in Sales Rep Overtime Case More...

• Watson Pharmaceuticals, Inc. (WPI) Confirms Lialda® Patent Challenge More...

• 400 Jobs to Go as Patheon Inc. (PTI.TO) Winds Down Swindon Operation More...

• GE Healthcare Life Sciences Completes Acquisition of Xcellerex, Inc.More...

• Spectrum Pharmaceuticals, Inc. (SPPI) and Allos Therapeutics, Inc. (ALTH) Announce Extension of Previously Announced Tender Offer for Shares of Allos Therapeutics More...

• Aeras Global TB Vaccine Foundation and Infectious Disease Research Institute (IDRI) Sign Agreement to Jointly Develop Novel Tuberculosis Vaccine More...

• SK Bio-Pharmaceuticals Enters into a Licensing Agreement With Hanmi Pharmaceutical, Co., Ltd More...

• Genetic Technologies Limited (GTG.AX) Executes Settlement and License Agreement With GeneSeek Inc. More...

• TAP Biosystems Collaborates With OU to Develop Biomimetic 3D CNS Models Novel Approach Could Contribute to Reducing Number of Pre-Clinical Animal Studies More...

• Dr. Philippe Calais Appointed Chief Executive Officer of ANTISENSE PHARMA GmbH More...

• AMAG Pharmaceuticals, Inc. (AMAG) Appoints William Heiden as President and Chief Executive Officer More...

• LaserGen, Inc. Names Dr. Mimi Healy as CEO More...

• RXi Pharmaceuticals (RXII) Appoints Industry Veteran Dr. Geert Cauwenbergh as President and Chief Executive Officer More...

• Achillion Pharmaceuticals, Inc. Reports First Quarter 2012 Financial Results More...

• A.P. Pharma, Inc. (APPA) Announces First Quarter 2012 Financial Results and Recent Corporate Progress More...

• Auxilium Pharmaceuticals (AUXL) Announces First Quarter 2012 Financial Results More...

• Bioniche Life Sciences Inc. (BNC) Reports Q3, Fiscal 2012 Results More...

• Biodel Inc. (BIOD) Reports Second Quarter Fiscal Year 2012 Financial Results More...

• Pfizer Inc. (PFE)'s RA Drug Wins FDA Panel Support More...

• Johnson & Johnson (JNJ) Seeks Further FDA Thrombosis OK for Xarelto More...

• Janssen Research & Development Submits Supplemental New Drug Application to U.S. FDA for XARELTO® (rivaroxaban) to Reduce the Risk of Stent Thrombosis in Patients with Acute Coronary Syndrome More...

• Biogen Idec, Inc. (Massachusetts) (BIIB) Release: US and EU Regulatory Authorities Accept Oral BG-12 Marketing Applications for Review More...

• Lethal Injection Drug from Naari AG Held by Nebraska is Recalled More...

• GlaxoSmithKline (GSK): We Complied With Indian Rules for Drug Approval More...

• Aastrom Biosciences, Inc. (ASTM) Announces First Patient Enrolled in REVIVE Phase 3 Clinical Trial of Ixmyelocel-T More...

• FDA and Repros Therapeutics Inc. (RPRX) Reach Agreement for Androxal® Registration Program More...

• Clal Biotechnology Industries Release: Andromeda Announces That Further Data Analyses Support Primary Endpoint in Andromeda Biotech's Phase III Clinical Study More...

• Celgene Corporation (CELG) Release: The New England Journal of Medicine Reports on Three Phase III REVLIMID® (lenalidomide) Trials in Patients with Newly Diagnosed Multiple Myeloma More...

• Testosterone-Fuelled Infantile Males Might Be a Product of Mom's Behaviour,University Of Montreal Study More...

• Kids Who Sleep With Parents Tend to Be "Slimmer," Copenhagen University Hospital Study More...

• Stem Cell Shield "Could Protect Cancer Patients," Cancer Research UK Cambridge Research Institute Study More...

• Why Do People Choke When the Stakes Are High?, California Institute of Technology Study More...

• Genes and Vascular Risk Modify Effects of Aging on Brain and Cognition,Wayne State University Study More...

• Quick-Med Technologies (QMDT) to Receive an Eighth NIMBUS(R) Patent More...

• Nitto Denko Corporation (XETRA: ND5.DE) Obtains US Patent for Antifibrotic Therapies with Molecular Targeting DDS Technology More...

• TrovaGene, Inc., Announces Issuance of European Patent for Detection of Pathogenic Infections More...

• Lipitor Clone Lifts Ranbaxy Laboratories (RANBAXY.BO) While Pfizer Inc. (PFE) Bids Drug Goodbye More...

• Roche (RHHBY) Wins UK National Institute for Clinical Excellence (NICE) Backing for Tarceva in Advanced Lung Cancer More...

• Johnson & Johnson (JNJ) Opens Doxil Rationing Program to New Patients More...

• Teijin Pharma's Febuxostat (FEBURIC) Launches in Taiwan - Novel Drug for Treatment of Hyperuricemia With Gout More...

• TherapeuticsMD, Inc. Launches vitaMedMD RediChew RX, the First Daily Chewable Prescription Prenatal Vitamin with Quatrefolic More...